Clinical Oncology Next Generation Sequencing Market-Companies Are Investing In Workflow Automation & DataDriven Medicine

EINPRESSWIRE Press Release
Clinical Oncology Next Generation Sequencing Market Report 2021: COVID-19 Growth And Change To 2030

Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, March 25, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

Clinical oncology next generation sequencing market research finds that companies in the industry are increasingly investing in automation of workflow to increase precision and reduce the sample-to-sample variability. For instance, Agilent automation solutions have developed an automation system that allows increasing the number of reactions that can perform in parallel and reduces the amount of sample processing time, thus increasing the number of samples which can be processed while reducing the variability amount from sample to sample. Companies such as Sophia Genetics are also investing in data-driven medicine that looks into automating DNA sequencing to better diagnose and treat patients.

Major players in the market clinical oncology next generation sequencing industry are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences.

Read More On The Global Clinical Oncology Next Generation Sequencing Market Report:
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report-2020-30-covid-19-growth-and-change

Global clinical oncology next generation sequencing market analysis shows that the market is expected to grow from $0.44 billion in 2020 to $0.56 billion in 2021 at a compound annual growth rate (CAGR) of 27.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The clinical oncology market is expected to reach $1.05 billion in 2025 at a CAGR of 17%.

The clinical oncology next generation sequencing market covered in this report is segmented by technology into ion semiconductor sequencing, pyrosequencing, synthesis sequencing, real time sequencing, ligation sequencing, reversible dye termination sequencing, nano-pore sequencing. The global clinical oncology next generation sequencing market is also segmented by application into screening, companion diagnostics, other diagnostics and by end user into hospital laboratories, clinical research organizations, diagnostic laboratories.

Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides clinical oncology next generation sequencing market overview, forecast clinical oncology next generation sequencing market size and growth for the whole market, clinical oncology next generation sequencing market segments, and geographies, clinical oncology next generation sequencing market trends, clinical oncology next generation sequencing market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Clinical Oncology Next Generation Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report-2020-30-covid-19-growth-and-change

Next Generation Sequencing Market – By Product Type (Kits And Consumables, Software, Instruments), By Technology (Ion Semiconductor Sequencing, Sequencing by Synthesis, Single-molecule Real-time Sequencing, Other Sequencing Technologies, Nanopore Sequencing), By Application (Drug Discovery, Diagnostics, Other Applications, Telepsychiatry), And By Region, Opportunities And Strategies – Global Next Generation Sequencing Market Forecast To 2030
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

PCR And Realtime PCR testing Global Market Report 2021: COVID-19 Implications And Growth To 2030
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-and-real-time-polymerase-chain-reaction-pcr-testing-market-global-report-2020-2030-covid-19-implications-and-growth

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn